Patents
Patents for C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809)
09/2011
09/15/2011US20110224183 16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity
09/15/2011US20110224182 Salts of (3-0-(3',3'-dimethylsuccinyl) betulinic acid and solid state forms thereof
09/14/2011CN102180933A Preparation method of skunk bugbane monomer components
09/07/2011EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions
08/2011
08/31/2011EP1828222B9 Process for the preparation of drospirenone
08/31/2011CN101376669B Preparation of 6-O-beta-D- glucosyl-3,6,16,25-tetrahydroxy cycloartane
08/18/2011CA2789195A1 Derivatives of betulin
08/03/2011CN1859917B Medicine and food/beverage for ameliorating hyperglycemia
07/2011
07/20/2011CN101456891B Method for extracting oryzanol from rice bran oil soapstock
07/14/2011DE102010004452A1 Preparing drospirenone comprises reacting methyleneprasterone with strong base and with lithium and bromopropyl-trimethylsilylether, removing trimethylsilyl-protecting group and oxidatively cyclizing methylene-hydroxy-(propanol)-prasterone
07/14/2011DE102010004450A1 Making drospirenone, useful as hormonal contraceptive, comprises reacting methylenedienedione with strong base and bromopropyl-trimethylsilylether, removing trimethylsilyl group and cyclizing methylene-hydroxy-(propanol)-androst-dien-one
07/06/2011EP2340257A1 Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents
06/2011
06/30/2011US20110160167 Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists
06/30/2011DE102009038972A1 Producing drospirenone, useful as hormonal contraceptives, by oxidatively converting hydroxy-dimethylenandrostane-one to hydroxy-dimethylenandrostan-dione, eliminating hydroxy group, followed by reacting with 1-halopropan-3-oxy
06/23/2011US20110152229 Betulinic acid derivatives as anti-hiv agents
06/22/2011CN102101880A Preparation method and application of radix astragali saponin
06/16/2011US20110144363 Process for obtaining 17-spirolactones in steriods
06/16/2011US20110144071 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs
06/16/2011US20110144069 Compounds for treating viral infections
06/15/2011CN102093456A Method for extracting astragaloside IV from astragalus
06/15/2011CN101220036B Extraction of active ingredient such as betulinic acid from common camptotheca fruit with clean method
06/14/2011US7960368 Bismethylene-17A carbolactones and related uses
06/08/2011CN102086224A Preparation method of Abrusoside D
06/08/2011CN101343306B Method for synthesis of 6,7-methylene sterides
05/2011
05/31/2011US7951965 Having semiconductor properties of electron transfer, electroluminescence, and photoluminescence. Intermolecular stacking can be avoided, enhanced electron-luminescent emission stability, applied as a light-emitting material in organic EL devices
05/26/2011WO2011060634A1 23-hydroxy-betulinic acid derivatives, preparation methods and uses thereof
05/04/2011CN102046646A C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter
05/04/2011CN102040666A Method for separating astragalus polysaccharide and astragalin astragaloside by ultrasonic film chromatography
05/04/2011CN102040650A Method for constructing sterides-6beta, 7beta-methylene structure by cascade reaction
04/2011
04/27/2011CN102030800A Abies holophylla triterpenoid compound, extraction separation thereof and application thereof
04/27/2011CN102030799A Cycloastragenol-6-O-beta-D glucoside monohydrate and crystal thereof
04/26/2011CA2623639C Agent for improving insulin resistance
04/05/2011CA2330916C Triterpene compositions and methods for use thereof
03/2011
03/31/2011US20110077228 Novel c-21-keto lupane derivatives preparation and use thereof
03/31/2011US20110077227 Novel lupane derivatives
03/30/2011CN101061132B Method for preparing 17- hydroxy- 6beta, 7beta, 15beta, 16beta- bisacrylamide- 17alpha- pregnane- 4- ene- 3- ketone- 21- carboxylate gamma- lactone and key intermediate used for the said method
03/23/2011EP2297177A1 C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter
03/17/2011WO2010114305A3 Pegylated betulin derivative, and cosmetic composition containing the same
03/03/2011DE102009031908A1 Producing drospirenone, useful as hormonal contraceptives, by oxidatively converting hydroxy-dimethylenandrostane-one to hydroxy-dimethylenandrostan-dione, eliminating hydroxy group, followed by reacting with 1-halopropan-3-oxy
03/01/2011US7897587 Topical dermatological formulations and use thereof
02/2011
02/24/2011US20110046402 Novel method and intermediates for preparing 19-norsteroid compounds
02/23/2011CN101981047A Novel lupane derivatives
02/16/2011CN101977924A Novel c-21-keto lupane derivatives preparation and use thereof
02/16/2011CN101972246A Medicament for treating cancer, preparation method thereof and application thereof to preparation of medicaments
02/16/2011CN101503455B Method for preparing drospiroenon and intermediate
02/16/2011CN101298465B Improved synthetic method of cyproterone acetate
02/16/2011CN101033245B Preparation method and application of pedunculoside
02/09/2011CN101967174A Composition preparation and purification process of cycloartenyl ferulate
02/09/2011CN101128476B 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
02/09/2011CN101117349B A macrocyclic oxidation substituted pentacyclic triterpanoids derivative and preparation method and use thereof
01/2011
01/26/2011CN101061133B Industrial method for preparing 17- hydroxy- 6beta, 7beta, 15beta, 16beta- bisacrylamide- 3- oxo- 17alpha- pregnane- 4- ene- 3- ketone- 21- carboxylate gamma- lactone and key intermediate used for the
01/20/2011US20110015162 15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative
01/13/2011US20110008634 Rust inhibitor and surface treatment metal material
01/11/2011US7868193 Contraceptives; hormone replacement therapy
01/06/2011US20110003022 Composition and Method
01/05/2011DE102009031909A1 Preparing drospirenone, useful e.g. as hormonal contraceptive, comprises reacting dimethylen-androst-4-en-dione with halo propionic acetaldehyde compound, converting dimethylen-hydroxy-(dialkoxypropyl) -androst-4-ene to spirol and oxidizing
01/05/2011DE102009031907A1 Preparing drospirenone, useful as a component of hormonal contraceptives, comprises reacting dimethylen-androst-4-en-3,17-dione with o-(3-halopropionic acid)-trialkylester to give trialkoxypropyl-hydroxy-dimethylene-androst-4-en-3-one
12/2010
12/30/2010US20100331292 Substituted 16,17-annellated steriod compounds for use in womens healthcare
12/30/2010US20100331291 Process for the preparation of drospirenone
12/29/2010EP2266998A1 Process for obtaining 17-spirolactones in steroids
12/29/2010EP2265629A2 Bismethylene-17 carbolactones and related uses
12/29/2010CN101117348B A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof
12/29/2010CN101098702B Drugs, food or drink for improving pancreatic functions
12/28/2010US7858606 Triterpenoid derivatives
12/23/2010WO2010146042A1 Process for obtaining 17-spirolactones in steroids
12/23/2010US20100324003 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders
12/16/2010WO2010142705A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
12/16/2010US20100317638 Neuroactive 13,24-Cyclo-18,21-Dinorcholanes and Structurally Related Pentacylic Steroids
12/16/2010CA2764252A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
12/15/2010EP1828222B1 Process for the preparation of drospirenone
12/15/2010CN101918427A 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/15/2010CN101918426A 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/14/2010US7851641 Compounds useful for treating neurodegenerative disorders
12/14/2010US7851462 Methods and compositions for inhibiting tumor growth
12/09/2010US20100311706 Method of treatment of allergic rhinitis
12/08/2010EP2257567A1 Novel 17 beta lupane derivatives
12/08/2010EP2038294B1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
12/08/2010CN1594355B Cyclovirobuxinum D crystal, its mono-methanol crystal, and preparation and use thereof
12/08/2010CN101910192A 19-nor-steroid derivatives with a 15alpha,16alpha-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives
12/08/2010CN101910191A 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid gamma-lactone derivative, use thereof, and medicament containing said derivative
12/08/2010CN101910190A 17-hydroxy-19-nor-21-carboxylic acid-steroid gamma-lactone derivative, use thereof, and medicament containing the derivative
12/08/2010CN101328200B Antineoplastic compound, preparation and use thereof
12/01/2010CN101306203B Hydrophilic polymer-boxwood extract conjugate and its medicine composition
11/2010
11/25/2010WO2010134830A1 Triterpenoid derivatives useful as antiproliferative agents
11/25/2010WO2010133687A1 Cycloartanone derivatives with anticancer activity
11/25/2010CA2795981A1 Compositions and methods for increasing telomerase activity
11/24/2010EP2253641A2 A process for preparing drospirenone and intermediate thereof
11/18/2010US20100292197 Compositions and Methods for Increasing Telomerase Activity
11/18/2010US20100292184 17beta-cyano-19-androst-4-ene derivative, its use and medicaments comprising the derivative
11/17/2010EP2250185A1 Novel lupane derivatives
11/11/2010US20100286106 Methods and apparatus for treating the prostate
11/10/2010CN1569884B Method for preparing astragaloside and its use in preparation of drug for preventing and treating diabetic nephropathy
11/03/2010EP2246049A2 Pharmaceutical composition and dosage forms for administration of hydrophobic drugs
10/2010
10/14/2010WO2010118023A1 Methods for the preparation of drospirenone
10/13/2010EP2238151A1 17-hydroxy-19-nor-21-carboxylic acid-steroid -lactone derivative, use thereof, and medicament containing the derivative
10/13/2010EP2238150A1 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID y-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE
10/13/2010EP2238149A2 19-nor-steroid derivatives with a 15 ,16 -methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives
10/13/2010EP2238148A1 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
10/13/2010EP2238147A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
10/07/2010WO2010114305A2 Pegylated betulin derivative, and cosmetic composition containing the same
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 19